Dr. Eva Feldman to headline fall Health Science Lecture
Dr. Eva Feldman will headline the fall Health Science Lecture on Wednesday, Oct. 2, with an update on her landmark trial of a stem cell therapy for ALS. The trial, in which patients receive the surgical implantation of stem cells directly to their spinal cords, is expected to move into Phase 2 this fall in Ann Arbor.
The lecture takes place from 6-7 p.m. in the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building on the University of Michigan campus. It is open to the general public; no registration is required. Click here for directions.
The Health Science Lecture Series is sponsored by the Taubman Institute, the Program for Biology and a number of student organizations. The lectures will be held quarterly on the U-M campus and will focus on a wide variety of topics including medical research, public health, bioethics, evolutionary biology, epidemiology and many others.
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Call for applications
Taubman Institute to offer six new scholar grants
The institute is accepting applications through Dec. 1 for its flagshop Taubman Scholar grant program, which is open to clinician-scientists on the U-M Medical School Faculty. Grants are $150,000 per year for three years.
Click here for details
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
Is there a link between tonsils and psoriasis?
Trial tested the effect of tonsillectomy on the skin disease
Taubman Emerging Scholar Dr. Johann Gudjonsson and colleagues found that people who had their tonsils removed showed improvment.
Click here to read the entire story
Fall Visiting Professor Lectures schedule
Distinguished guest speakers include experts in lung, muscle and nerve diseases
Click here for the lineup
Breast cancer clinical trial enrolling patients
Research by Taubman Scholar Dr. Max Wicha into breast cancer stem cells is the basis for a new human clinical trial of the drug Reparixin, which scientists hope will curb the growth of the tumor-fueling cells.